Gene Fragment Market
Gene Fragment Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Gene Fragment Market Size and Growth
The Gene Fragment market is experiencing significant growth, driven by increasing demand for personalized medicine and genetic research. As of 2023, the market size is estimated to reach $1.5 billion, with a projected CAGR of 8% over the next five years. Emerging technologies and expanding applications are reshaping market dynamics.
Companies Covered
(Covid 19 Impact Covered)
◍ Integrated DNA Technologies
◍ Thermo Scientific
◍ Eurofins Scientific
◍ GenScript Biotech
◍ Azenta Life Sciences
◍ Twist Bioscience
◍ Synbio Technologies
◍ Bio Basic
◍ BiOligo Biotechnology
The gene fragment market features key players like Integrated DNA Technologies, Thermo Scientific, and GenScript Biotech. These companies offer custom DNA synthesis, high-throughput capabilities, and innovative solutions, driving market growth. Their ability to deliver precise gene fragments supports diverse applications, enhancing research and development in biotechnology and pharmaceuticals.
**Sales Revenue (estimates)**:
- Integrated DNA Technologies: ~$1 billion
- Thermo Scientific: Part of Thermo Fisher Scientific, ~$40 billion
- GenScript Biotech: ~$500 million
- Twist Bioscience: ~$140 million
Request Sample Report
Market Segmentation
By Application
◍ CRISPR-based Genome Editing
◍ Antibody Engineering
◍ Cloning Process
◍ Others
By Product
◍ 0-999 bp ◍ 1000-1999 bp ◍ 2000-3999 bp
4000+ bp
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
